La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Canada7508
Oleh Hornykiewicz28
Canada Sauf Oleh Hornykiewicz" 7481
Oleh Hornykiewicz Sauf Canada" 1
Canada Et Oleh Hornykiewicz 27
Canada Ou Oleh Hornykiewicz 7509
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 27.
Ident.Authors (with country if any)Title
000658 Junchao Tong [Canada] ; Lee-Cyn Ang [Canada] ; Belinda Williams [Canada] ; Yoshiaki Furukawa [Japon] ; Paul Fitzmaurice [Nouvelle-Zélande] ; Mark Guttman [Canada] ; Isabelle Boileau [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada]Low Levels of Astroglial Markers in Parkinson's Disease: Relationship to α-Synuclein Accumulation
000A22 Christian Pifl [Autriche] ; Alex Rajput [Canada] ; Harald Reither [Autriche] ; Javier Blesa ; Carmen Cavada [Espagne] ; José A. Obeso ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Autriche]Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
001354 Christian Pifl [Autriche] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche]Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non‐motor symptoms
001A40 Junchao Tong [Canada] ; Yoshiaki Furukawa [Canada, Japon] ; Allan Sherwin [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada]HETEROGENEOUS INTRASTRIATAL PATTERN OF PROTEINS REGULATING AXON GROWTH IN NORMAL ADULT HUMAN BRAIN
001B39 Junchao Tong [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon]Brain -synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation
001D37 JUNCHAO TONG [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon]Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation
001F26 Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada]Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease
002238 Stephen J. Kish [Canada, Niger] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Canada] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada]Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
002737 Junchao Tong [Canada] ; Oleh Hornykiewicz ; Stephen J. KishInverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline.
002920 JUNCHAO TONG [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada]Inverse relationship between brain noradrenaline level and dopamine loss in parkinson disease : A possible neuroprotective role for noradrenaline
002C61 Fre De Ric Calon ; Mehdi Dridi ; Oleh Hornykiewicz [Autriche] ; Paul J. Be Dard [Canada] ; Ali H. Rajput ; The Re Se Di PaoloIncreased adenosine A2A receptors in the brain of Parkinson’s disease patients with dyskinesias
002D75 Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloLevodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
002F48 Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications
003033 Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche]Clinical–Pathological study of levodopa complications
003076 Frédéric Calon [Canada] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias
003329 Poornima K. Tekumalla [États-Unis] ; Frédéric Calon [Canada] ; Zia Rahman [États-Unis] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Therese Di Paolo [Canada] ; Paul J. Bedard [Canada] ; Eric J. Nestler [États-Unis]Elevated levels of ΔFosB and RGS9 in striatum in Parkinson's disease
003978 Kelly Macmillan Muenter [États-Unis] ; Lysia S. Forno [États-Unis] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] ; Demetrius M. Maraganore [États-Unis] ; Richard J. Caselli [États-Unis] ; Haruo Okazaki [États-Unis] ; Frank M. Howard Jr. [États-Unis] ; Barry J. Snow [Nouvelle-Zélande] ; Donald B. Calne [Canada]Hereditary form of parkinsonism—dementia
003E41 Michel P. Furukawa [Japon, Canada] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Yumiko Shimuzu [Japon] ; Tetsuzo Tagawa [Japon] ; Hideo Mori [Japon] ; Masayuki Yokochi [Japon] ; Hirotaro Narabayashi [Japon] ; Oleh Hornykiewicz [Autriche] ; Yoshikuni Mizuno [Japon] ; Stephen J. Kish [Canada]GTP‐cyclohydrolase I gene mutations in hereditary progressive and dopa‐responsive dystonia
004C30 Douglas S. Gilbert [Canada] ; Stephen J. Kish [Canada] ; Li-Jan Chang [Canada] ; Caryl Morito [Canada] ; Kathleen Shannak [Canada] ; Oleh Hornykiewicz [Canada, Autriche]Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates
004E74 Mary E. Kish [Canada] ; Ali Rajput [Canada] ; Joseph Gilbert [Canada] ; Bohdan Rozdilsky [Canada] ; Li-Jan Chang [Canada] ; Kathleen Shannak [Canada] ; Oleh Hornykiewicz [Canada, Autriche]Elevated γ‐aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: Correlation with striatal dopamine loss
004F36 Stephen J. Kish [Canada] ; Caryl Morito [Canada] ; Oleh Hornykiewicz [Canada]Glutathione peroxidase activity in Parkinson's disease brain
005186 Tyrone Lee [Canada] ; Philip Seeman [Canada] ; Oleh Hornykiewicz [Canada] ; Juan Bilbao [Canada] ; John Deck [Canada] ; Wallace W. Tourtellotte [États-Unis]Parkinson's disease: low density and presynaptic location of D3 dopamine receptors
005391 Oleh Hornykiewicz [Canada]Parkinsons disease and its chemotherapy
005401 Oleh Hornykiewicz [Canada]The mechanisms of action of L-dopa in Parkinson's disease
005402 Oleh Hornykiewicz [Canada]Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders
005425 Oleh Hornykiewicz [Canada]DOPAMINE IN THE BASAL GANGLIA: Its Role and Therapeutic Implications (Including the Clinical Use of L-DOPA)
005488 Charles H. Hockman [Canada] ; Kenneth G. Lloyd [Canada] ; Irene J. Farley [Canada] ; Oleh Hornykiewicz [Canada]Experimental midbrain lesions: neurochemical comparison between the animal model and Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022